BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11327761)

  • 1. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
    Nagata T; Werner MH
    J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
    Bravo J; Li Z; Speck NA; Warren AJ
    Nat Struct Biol; 2001 Apr; 8(4):371-8. PubMed ID: 11276260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.
    Nagata T; Gupta V; Sorce D; Kim WY; Sali A; Chait BT; Shigesada K; Ito Y; Werner MH
    Nat Struct Biol; 1999 Jul; 6(7):615-9. PubMed ID: 10404214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.
    Ogawa E; Inuzuka M; Maruyama M; Satake M; Naito-Fujimoto M; Ito Y; Shigesada K
    Virology; 1993 May; 194(1):314-31. PubMed ID: 8386878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta.
    Goger M; Gupta V; Kim WY; Shigesada K; Ito Y; Werner MH
    Nat Struct Biol; 1999 Jul; 6(7):620-3. PubMed ID: 10404215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
    Yan J; Liu Y; Lukasik SM; Speck NA; Bushweller JH
    Nat Struct Mol Biol; 2004 Sep; 11(9):901-6. PubMed ID: 15322525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of core binding factor beta and map of the CBF alpha binding site.
    Huang X; Peng JW; Speck NA; Bushweller JH
    Nat Struct Biol; 1999 Jul; 6(7):624-7. PubMed ID: 10404216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
    Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
    Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
    Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y
    EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional domains of the t(8;21) fusion protein, AML-1/ETO.
    Lenny N; Meyers S; Hiebert SW
    Oncogene; 1995 Nov; 11(9):1761-9. PubMed ID: 7478604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations.
    Cunningham ML; Seto ML; Hing AV; Bull MJ; Hopkin RJ; Leppig KA
    Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):78-85. PubMed ID: 16463420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic potential of the RUNX gene family: 'overview'.
    Ito Y
    Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runt domains take the lead in hematopoiesis and osteogenesis.
    Werner MH; Shigesada K; Ito Y
    Nat Med; 1999 Dec; 5(12):1356-7. PubMed ID: 10581073
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.
    Zhang L; Li Z; Yan J; Pradhan P; Corpora T; Cheney MD; Bravo J; Warren AJ; Bushweller JH; Speck NA
    J Biol Chem; 2003 Aug; 278(35):33097-104. PubMed ID: 12807883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
    Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
    Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core binding factor genes and human leukemia.
    Hart SM; Foroni L
    Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
    J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
    Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
    Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed mutagenesis supports a three-dimensional model of the runt domain.
    Levanon D; Eisenstein M; Groner Y
    J Mol Biol; 1998 Apr; 277(3):509-12. PubMed ID: 9533875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1.
    Bae SC; Yamaguchi-Iwai Y; Ogawa E; Maruyama M; Inuzuka M; Kagoshima H; Shigesada K; Satake M; Ito Y
    Oncogene; 1993 Mar; 8(3):809-14. PubMed ID: 8437866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.